{"result": "(\"entity\"<|>HPP<|>EVENT<|>HPP refers to Hyperparathyroidism, a condition that requires careful diagnosis and management based on biochemical findings rather than imaging studies.)\n##\n(\"entity\"<|>SPECT<|>EVENT<|>SPECT refers to Single Photon Emission Computed Tomography, a type of imaging that provides three-dimensional images to improve the detection of parathyroid glands.)\n##\n(\"entity\"<|>MIBI<|>EVENT<|>MIBI refers to Methoxyisobutylisonitrile, a radiopharmaceutical used in imaging studies for localizing parathyroid adenomas.)\n##\n(\"entity\"<|>MELMED S<|>PERSON<|>Melmed S is an author referenced in the context of endocrinology, contributing to the Williams Textbook of Endocrinology.)\n##\n(\"entity\"<|>POLONSKY KS<|>PERSON<|>Polonsky KS is an author referenced in the context of endocrinology, contributing to the Williams Textbook of Endocrinology.)\n##\n(\"entity\"<|>REED LARSEN P<|>PERSON<|>Reed Larsen P is an author referenced in the context of endocrinology, contributing to the Williams Textbook of Endocrinology.)\n##\n(\"entity\"<|>KRONENBERG HM<|>PERSON<|>Kronenberg HM is an author referenced in the context of endocrinology, contributing to the Williams Textbook of Endocrinology.)\n##\n(\"entity\"<|>YIP L<|>PERSON<|>Yip L is an author referenced in the context of preoperative localization for parathyroid surgery.)\n##\n(\"entity\"<|>SILVERBERG SJ<|>PERSON<|>Silverberg SJ is an author referenced in the context of preoperative localization for parathyroid surgery.)\n##\n(\"entity\"<|>EL-HAJJ FULEIHAN G<|>PERSON<|>El-Hajj Fuleihan G is an author referenced in the context of preoperative localization for parathyroid surgery.)\n##\n(\"entity\"<|>SALLY CE<|>PERSON<|>Sally CE is an editor referenced in the context of preoperative localization for parathyroid surgery.)\n##\n(\"entity\"<|>UPTODATE INC<|>ORGANIZATION<|>UpToDate Inc is a medical resource providing clinical information, referenced for its content on parathyroid surgery localization.)\n##\n(\"relationship\"<|>MELMED S<|>WILLIAMS TEXTBOOK OF ENDOCRINOLOGY<|>Melmed S is one of the authors of the Williams Textbook of Endocrinology<|>8)\n##\n(\"relationship\"<|>POLONSKY KS<|>WILLIAMS TEXTBOOK OF ENDOCRINOLOGY<|>Polonsky KS is one of the authors of the Williams Textbook of Endocrinology<|>8)\n##\n(\"relationship\"<|>REED LARSEN P<|>WILLIAMS TEXTBOOK OF ENDOCRINOLOGY<|>Reed Larsen P is one of the authors of the Williams Textbook of Endocrinology<|>8)\n##\n(\"relationship\"<|>KRONENBERG HM<|>WILLIAMS TEXTBOOK OF ENDOCRINOLOGY<|>Kronenberg HM is one of the authors of the Williams Textbook of Endocrinology<|>8)\n##\n(\"relationship\"<|>YIP L<|>UPTODATE INC<|>Yip L is an author contributing to UpToDate's content on parathyroid surgery<|>7)\n##\n(\"relationship\"<|>SILVERBERG SJ<|>UPTODATE INC<|>Silverberg SJ is an author contributing to UpToDate's content on parathyroid surgery<|>7)\n##\n(\"relationship\"<|>EL-HAJJ FULEIHAN G<|>UPTODATE INC<|>El-Hajj Fuleihan G is an author contributing to UpToDate's content on parathyroid surgery<|>7)\n##\n(\"relationship\"<|>SALLY CE<|>UPTODATE INC<|>Sally CE is an editor contributing to UpToDate's content on parathyroid surgery<|>7)\n##\n(\"relationship\"<|>MIBI<|>SPECT<|>MIBI is a radiopharmaceutical used in SPECT imaging for localizing parathyroid adenomas<|>9)\n##\n(\"relationship\"<|>HPP<|>MIBI<|>HPP diagnosis may involve MIBI imaging to localize parathyroid adenomas<|>6)\n##\n(\"relationship\"<|>HPP<|>SPECT<|>HPP diagnosis may involve SPECT imaging to localize parathyroid adenomas<|>6)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: y presenta como ventaja una mayor sensibilidad para localizar adenomas paratiroideos en pacientes con nódulos tiroideos.\nD. La no localización del adenoma mediante pruebas de imagen no es criterio para no indicar la intervención si cumple criterios quirúrgicos. En estos casos debe realizarse exploración bilateral por un cirujano con experiencia.\n---\n# METABOLISMO FOSFOCÁLCICO, TUMORES NEUROENDOCRINOS Y MEN 7\n\n## COMENTARIO\n\nEl diagnóstico de HPP debe hacerse en función de los hallazgos bioquímicos. Los estudios de imagen no se utilizan como una herramienta de diagnóstico debido a las altas tasas de falsos positivos, que pueden oscilar entre el 5% y el 25% (opción C falsa: respuesta correcta). Además, un resultado de imagen positivo de un solo foco no excluye de forma fiable la presencia de enfermedad paratiroidea multiglandular. Los estudios de localización preoperatorios se utilizan para determinar si un paciente es o no candidato para un enfoque mínimamente invasivo.\n\nUna prueba con 99mTc-MIBI negativa no excluye el diagnóstico de HPP, ya que ocurre en el 12% a 25% de los pacientes con enfermedad. La exploración con sestamibi a menudo es poco reveladora o engañosa en pacientes con hiperplasia paratiroidea, adenomas paratiroi-deos múltiples y enfermedad tiroidea coexistente.\n\nLa tomografía computarizada por emisión de fotón único (SPECT o MIBI-SPECT) es una exploración tridimensional de sestamibi que proporciona imágenes de mayor resolución y mejora el rendimiento de la exploración de sestamibi. Las imágenes multidimensionales ilustran la profundidad de la glándula paratiroides o glándulas en relación con la tiroides y mejoran la detección de glándulas ectópicas, lo que facilita la paratiroidectomía mínimamente invasiva.\n\nLa SPECT-TAC agrega la capacidad de discriminar los adenomas paratiroideos de otros puntos de referencia anatómicos, lo que puede facilitar el procedimiento quirúrgico.\n\nSi es necesario, se puede obtener una exploración de la tiroides por sustracción utilizando dos radiotrazadores (escintigrafía de isótopos duales). El uso de tecnecio más un segundo radiotrazador como el pertecnetato (talio), 123I o 99mTc permite obtener imágenes selectivas de la glándula tiroides.\n\nAl igual que con las técnicas basadas en sestamibi, la sensibilidad del ultrasonido para la localización del adenoma paratiroideo se reduce en pacientes con nódulos tiroideos.\n\nReferencias:\n- Melmed S, Polonsky KS, Reed Larsen P, Kronenberg HM. Williams Textbook of Endocrinology. 13.ª ed. Philadelphia: Elsevier; 2016.\n- Yip L, Silverberg SJ, El-Hajj Fuleihan G. Preoperative localization for parathyroid surgery in patients with primary hyperparathyroidism. Sally CE, Rosen CJ, eds. UpToDate. Waltham, MA: UpToDate Inc. https://www.uptodate.com (acceso 6 de junio de 2019).\n\n## COMENTARIO\n\nLos pacientes sintomáticos o con una concentración sérica de calcio por encima de 14 mg/dl deben tratarse de manera intensiva habitualmente.\n\nLa prioridad es corregir la depleción de volumen extracelular presente casi siempre, normalmente con suero fisiológico a un ritmo de 4 l/día. La intensidad de la rehidratación debe estar relacionada con el estado de volumen del paciente y con el riesgo de causar o de empeorar una insuficiencia cardíaca congestiva o una ascitis. Hay que suspender los diuréticos, en especial las tiazidas.\n\nEl uso de furosemida o de otros diuréticos de asa potentes para favorecer la calciuresis puede empeorar la depleción de volumen extracelular si se realiza demasiado pronto en el curso del tratamiento. Es mejor evitar estos fármacos, excepto en circunstancias en las que una rehidratación intensiva no mejora la hipercalcemia grave o puede causar una insuficiencia cardíaca congestiva. En cualquier caso, no se recomienda una calciuresis prolongada mediante suero fisiológico sin la introducción temprana de un fármaco antirresortivo efectivo.\n\nLos bisfosfonatos intravenosos inhiben con rapidez la resorción ósea. Y en la actualidad son el tratamiento más apropiado de la hipercalcemia grave que se sabe o que se sospecha que está causada principalmente por resorción ósea osteoclástica. El calcio sérico suele bajar en 24 horas y alcanza el punto más bajo la semana siguiente a una inyección única, momento en que la concentración de calcio puede ser normal en el 70-90% de los pacientes tratados.\n\nLa calciton\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}